[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337742-105":59,"doc-detail-337742-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","extracellular-vesicles-in-non-small-cell-lung-cancer-stemness-and-clinical-applications","Extracellular vesicles in non-small cell lung cancer stemness and clinical applications","","Non-small cell lung carcinoma (NSCLC) is driven by cancer stem cells (CSCs) whose stem-like traits contribute to progression, metastasis, relapse, and therapeutic resistance. Extracellular vesicles (EVs) are membrane-bound nanoparticles that enable short- and long-range intercellular communication. This review summarizes how NSCLC CSC-derived EVs interact with the tumor microenvironment to enhance stemness, tumor progression, and metastasis. Mechanistic insights are linked to emerging diagnostic and prognostic biomarkers and therapeutic strategies to target the NSCLC CSC niche.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extracellular-vesicles-in-non-small-cell-lung-cancer-stemness-and-clinical-applications/337742/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extracellular-vesicles-in-non-small-cell-lung-cancer-stemness-and-clinical-applications/337742.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role do cancer stem cells play in NSCLC?","Question",{"text":113,"@type":114},"Cancer stem cells (CSCs) with stem-like properties drive NSCLC progression, metastasis, relapse, and therapeutic resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do extracellular vesicles (EVs) contribute to communication in NSCLC?",{"text":118,"@type":114},"EVs are membrane-bound nanoparticles secreted by cells, carrying bioactive cargo that supports intercellular communication and can promote treatment resistance and other malignant processes.",{"name":120,"@type":111,"acceptedAnswer":121},"What clinical applications are discussed for NSCLC EVs?",{"text":122,"@type":114},"The review connects EV mechanisms to the development of novel NSCLC diagnostic and prognostic biomarkers and strategies to therapeutically target the CSC niche.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337742,1790172842,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Review  \nPUBLISHED 03 May 2024  \nDOI 10.3389/fimmu.2024.1369356  \nOPEN ACCESS  \nEDITED BY  \nGiulia Bertolini,  \nFondazione IRCCS Istituto Nazionale Tumori, Italy  \nREVIEWED BY  \nValentina Masciale,  \nUniversity Hospital of Modena, Italy Cristina Borzi,  \nNational Cancer Institute Foundation (IRCCS), Italy  \n*CORRESPONDENCE Verline Justilien  \n [Justilien.verline@mayo.edu](Justilien.verline@mayo.edu)  \nRECEIVED 12 January 2024  \nACCEPTED 18 April 2024  \nPUBLISHED 03 May 2024  \nCITATION  \nPandya P, Al-Qasrawi DS, Klinge S and Justilien V (2024) Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.  \nFront. Immunol. 15:1369356 .  \ndoi: 10.3389/fimmu.2024.1369356  \nCOPYRIGHT  \n© 2024 Pandya, Al-Qasrawi, Klinge and Justilien. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExtracellular vesicles in nonsmall cell lung cancer stemness and clinical applications  \nPrita Pandya 1,2, Dania S. Al-Qasrawi 1, Skyeler Klinge 1,3 and Verline Justilien 1,4*  \n1 Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States, 2Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States, 3 Department of Biology, University of North Florida, Jacksonville, FL, United States, 4Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, United States  \nNon-small cell lung carcinoma (NSCLC) accounts for 85% of lung cancers, the leading cause of cancer associated deaths in the US and worldwide. Within NSCLC tumors, there is a subpopulation of cancer cells termed cancer stem cells (CSCs) which exhibit stem-like properties that drive NSCLC progression, metastasis, relapse, and therapeutic resistance. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells that carry vital messages for short- and long-range intercellular communication. Numerous studies have implicated NSCLC CSC-derived EVs in the factors associated with NSCLC lethality. In this review, we have discussed mechanisms of EV-directed crosstalk between CSCs and cells of the tumor microenvironment that promote stemness, tumor progression and metastasis in NSCLC. The mechanistic studies discussed herein have provided insights for developing novel NSCLC diagnostic and prognostic biomarkers and strategies to therapeutically target the NSCLC CSC niche.  \nKEYWORDS  \nnon-small cell lung cancer, cancer stem cells, extracellular vesicles, metastasis, tumor microenvironment, biomarkers, therapeutic targeting, oncogenic signaling  \n1 Introduction  \nLung cancer, an aggressive and heterogeneous disease, is the second most diagnosed cancer and the leading cause of cancer associated deaths worldwide (1) . Lung cancer is broadly grouped into two major histological types, non-small cell lung cancer (NSCLC) and small cell lung cancer, which account for approximately 85% and 15% of total diagnosed cases, respectively (2) . NSCLC is further classiﬁed into three main subtypes, adenocarcinoma (LUAD), squamous cell carcinoma (LUSC), and large cell carcinoma which exhibit distinct histopathology, cells and site of origin, and molecular proﬁles (3) . Despite major advances in NSCLC treatment and diagnosis including the introduction of molecular targeted therapies, immunotherapies and low-dose computed tomography  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nscreening, the 5-year survival rate for NSCLC is at a low 25% across all stages and 8.2% for patients with metastasis (1) . These poor survival rates are attributed to several factors including the frequent diagnosis of NSCLC cases in advanced or meta","cbCaidf9pwmNTrvb","https://ap.wps.com/l/cbCaidf9pwmNTrvb","pdf",2328671,17,"English","# Introduction\n# Key concepts and rationale for EV–CSC crosstalk\n# Implications for diagnosis, prognosis, and therapy","[{\"question\":\"What role do cancer stem cells play in NSCLC?\",\"answer\":\"Cancer stem cells (CSCs) with stem-like properties drive NSCLC progression, metastasis, relapse, and therapeutic resistance.\"},{\"question\":\"How do extracellular vesicles (EVs) contribute to communication in NSCLC?\",\"answer\":\"EVs are membrane-bound nanoparticles secreted by cells, carrying bioactive cargo that supports intercellular communication and can promote treatment resistance and other malignant processes.\"},{\"question\":\"What clinical applications are discussed for NSCLC EVs?\",\"answer\":\"The review connects EV mechanisms to the development of novel NSCLC diagnostic and prognostic biomarkers and strategies to therapeutically target the CSC niche.\"}]","Extracellular vesicles in non-small cell lung cancer stemness and clinical applications | PDF",1790020446,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45e06e7fc844f17b21f5f1bbea197047.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/876e6c0bbf147d0b1b67ba2d0435736e.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5319b4a401cb5d99866cfc268e865d13.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7094f026d7013e115bfe512a814e821.webp",980,1385]